Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O15360: Variant p.Gly809Asp

Fanconi anemia group A protein
Gene: FANCA
Feedback?
Variant information Variant position: help 809 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Aspartate (D) at position 809 (G809D, p.Gly809Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 809 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1455 The length of the canonical sequence.
Location on the sequence: help VHLGESRSALPEVDVGPPAP G AGLPVPALFDSLLTCRTRDS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         VHLGESRSALPEVDVGPPAPGAG-LPVPALFDSLLTCRTRDS

Mouse                         VHLGECRSMLPEVDPDVLAPSAGSLCVPDFLNSLLTCRTRD

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1455 Fanconi anemia group A protein
Alternative sequence 298 – 1455 Missing. In isoform 2.



Literature citations
Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ALA-266; SER-501 AND ASP-809; Mutations of the Fanconi anemia group A gene (FAA) in Italian patients.
Savino M.; Ianzano L.; Strippoli P.; Ramenghi U.; Arslanian A.; Bagnara G.P.; Joenje H.; Zelante L.; Savoia A.;
Am. J. Hum. Genet. 61:1246-1253(1997)
Cited for: VARIANT FANCA TYR-1359; VARIANTS ALA-266; SER-501 AND ASP-809; Sequence variation in the Fanconi anemia gene FAA.
Levran O.; Erlich T.; Magdalena N.; Gregory J.J.; Batish S.D.; Verlander P.C.; Auerbach A.D.;
Proc. Natl. Acad. Sci. U.S.A. 94:13051-13056(1997)
Cited for: VARIANTS FANCA PHE-244; CYS-435; ARG-492; PRO-817; PRO-845; LEU-1055; GLY-1117; GLU-1128; ALA-1131; PHE-1263 DEL; ARG-1302 AND ASP-1417; VARIANTS LYS-8; VAL-181; GLY-252; SER-501; LEU-739; ASP-809 AND ALA-1328; DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.
Ley T.J.; Mardis E.R.; Ding L.; Fulton B.; McLellan M.D.; Chen K.; Dooling D.; Dunford-Shore B.H.; McGrath S.; Hickenbotham M.; Cook L.; Abbott R.; Larson D.E.; Koboldt D.C.; Pohl C.; Smith S.; Hawkins A.; Abbott S.; Locke D.; Hillier L.W.; Miner T.; Fulton L.; Magrini V.; Wylie T.; Glasscock J.; Conyers J.; Sander N.; Shi X.; Osborne J.R.; Minx P.; Gordon D.; Chinwalla A.; Zhao Y.; Ries R.E.; Payton J.E.; Westervelt P.; Tomasson M.H.; Watson M.; Baty J.; Ivanovich J.; Heath S.; Shannon W.D.; Nagarajan R.; Walter M.J.; Link D.C.; Graubert T.A.; DiPersio J.F.; Wilson R.K.;
Nature 456:66-72(2008)
Cited for: VARIANTS [LARGE SCALE ANALYSIS] ALA-266; VAL-412; SER-501; ASP-809 AND PHE-1088;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.